Streetbeat News

Earnings Revenues

MBRX

Moleculin Biotech, Inc. held its Q4 2024 earnings conference call on March 24, 2025, featuring key executives including Chairman and CEO Walter Klemp, Senior CMO John Paul Waymack, and EVP and CFO Jonathan Foster. The call included a standard forward-looking statement disclaimer and was open to analysts from firms like Roth Capital Partners, Maxim Group, and H.C. Wainwright.

Portfolio Pulse from

March 24, 2025 | 3:00 pm

JAZZ

Jazz Pharmaceuticals (JAZZ) is highlighted as a promising investment opportunity, with a #2 (Buy) Zacks Rank and an impressive A-rated VGM Score. The company has demonstrated positive momentum, with shares up 2% in the past four weeks and 10 analysts revising earnings estimates upward for fiscal 2025.

Portfolio Pulse from

March 24, 2025 | 3:00 pm

CHWY

Chewy (CHWY) has gained 1.1% year-to-date, outperforming the Retail-Wholesale sector's average -2.9% decline. The company has a Zacks Rank of #2 (Buy) and shows improving analyst sentiment with a 2.5% increase in full-year earnings estimates.

Portfolio Pulse from

March 24, 2025 | 3:00 pm

AVA

Avista (AVA) has demonstrated robust performance in the Utilities sector, gaining 8.4% year-to-date compared to the sector's average of 4.1%. The company has a Zacks Rank of #2 (Buy) and has seen a 3.9% increase in full-year earnings estimates over the past three months, indicating improving analyst sentiment.

Portfolio Pulse from

March 24, 2025 | 3:00 pm

FUTU

KPLT

Futu Holdings (FUTU) has demonstrated impressive performance in 2023, with a 33% year-to-date return compared to the Business Services sector's -0.5%. The company holds a Zacks Rank of #1 (Strong Buy) and has seen a 10.2% increase in full-year earnings estimates over the past three months, indicating positive analyst sentiment.

Portfolio Pulse from

March 24, 2025 | 3:00 pm

VIRT

Zacks Research has added Virtu Financial (VIRT) to its Focus List, a curated portfolio of 50 stocks expected to outperform the market. The stock is currently ranked #1 (Strong Buy), with six analysts recently revising earnings estimates upward for fiscal 2025. Since being added to the list on July 31, 2023, VIRT has seen a remarkable 98.84% share price increase.

Portfolio Pulse from

March 24, 2025 | 2:45 pm

SRFM

Stonegate Capital Partners has initiated coverage on Surf Air Mobility Inc. (SRFM), noting the company's successful transition from a Transformation Phase to an Optimization Phase. The company reported Q4 and full-year financials, with On Demand service revenue growing 39% quarter-over-quarter and 28% year-over-year. SRFM also secured MOUs from seven customers to upgrade approximately 100 aircraft and obtained a $50.0M term loan.

Portfolio Pulse from

March 24, 2025 | 2:45 pm

ROKU

Wall Street analysts are overwhelmingly positive about Roku (ROKU), with an Average Brokerage Recommendation (ABR) of 1.97, which falls between Strong Buy and Buy. 51.9% of recommendations are Strong Buy, and 3.7% are Buy. The Zacks Rank also rates ROKU as a #2 (Buy) based on positive earnings estimate revisions.

Portfolio Pulse from

March 24, 2025 | 2:45 pm

TNK

Wall Street analysts have given Teekay Tankers (TNK) a strong buy recommendation, with an Average Brokerage Recommendation (ABR) of 1.60. However, the Zacks Rank tells a different story, assigning TNK a #5 (Strong Sell) rating due to declining earnings estimates and growing analyst pessimism about the company's earnings prospects.

Portfolio Pulse from

March 24, 2025 | 2:45 pm

OKTA

Okta (OKTA) has received positive analyst recommendations with an Average Brokerage Recommendation (ABR) of 2.00, indicating a 'Buy' rating. The Zacks Rank for the company is #2 (Buy), supported by a 64.7% increase in earnings estimate consensus over the past month. While brokerage recommendations are often overly optimistic, the Zacks Rank provides a more quantitative assessment of the stock's potential.

Portfolio Pulse from

March 24, 2025 | 2:45 pm